chr6-156778847-G-GGGC

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2

The NM_001374828.1(ARID1B):​c.1191_1193dupCGG​(p.Gly398dup) variant causes a disruptive inframe insertion change. The variant allele was found at a frequency of 0.00216 in 1,403,452 control chromosomes in the GnomAD database, including 20 homozygotes. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. G398G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0067 ( 6 hom., cov: 29)
Exomes 𝑓: 0.0016 ( 14 hom. )

Consequence

ARID1B
NM_001374828.1 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 4.68

Publications

1 publications found
Variant links:
Genes affected
ARID1B (HGNC:18040): (AT-rich interaction domain 1B) This locus encodes an AT-rich DNA interacting domain-containing protein. The encoded protein is a component of the SWI/SNF chromatin remodeling complex and may play a role in cell-cycle activation. The protein encoded by this locus is similar to AT-rich interactive domain-containing protein 1A. These two proteins function as alternative, mutually exclusive ARID-subunits of the SWI/SNF complex. The associated complexes play opposing roles. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016]
ARID1B Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina, ClinGen
  • Coffin-Siris syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001374828.1
BP6
Variant 6-156778847-G-GGGC is Benign according to our data. Variant chr6-156778847-G-GGGC is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 210313.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0067 (991/147922) while in subpopulation AFR AF = 0.02 (807/40308). AF 95% confidence interval is 0.0189. There are 6 homozygotes in GnomAd4. There are 484 alleles in the male GnomAd4 subpopulation. Median coverage is 29. This position passed quality control check.
BS2
High AC in GnomAd4 at 991 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ARID1BNM_001374828.1 linkc.1191_1193dupCGG p.Gly398dup disruptive_inframe_insertion Exon 1 of 20 ENST00000636930.2 NP_001361757.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ARID1BENST00000636930.2 linkc.1191_1193dupCGG p.Gly398dup disruptive_inframe_insertion Exon 1 of 20 2 NM_001374828.1 ENSP00000490491.2 Q8NFD5-3A0A6Q8NVI4

Frequencies

GnomAD3 genomes
AF:
0.00671
AC:
992
AN:
147818
Hom.:
6
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.0201
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00327
Gnomad ASJ
AF:
0.00292
Gnomad EAS
AF:
0.00205
Gnomad SAS
AF:
0.00322
Gnomad FIN
AF:
0.000710
Gnomad MID
AF:
0.00333
Gnomad NFE
AF:
0.00120
Gnomad OTH
AF:
0.00588
GnomAD2 exomes
AF:
0.00104
AC:
58
AN:
55508
AF XY:
0.00107
show subpopulations
Gnomad AFR exome
AF:
0.0179
Gnomad AMR exome
AF:
0.00154
Gnomad ASJ exome
AF:
0.00122
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000563
Gnomad NFE exome
AF:
0.000634
Gnomad OTH exome
AF:
0.00155
GnomAD4 exome
AF:
0.00163
AC:
2043
AN:
1255530
Hom.:
14
Cov.:
37
AF XY:
0.00161
AC XY:
993
AN XY:
617140
show subpopulations
African (AFR)
AF:
0.0243
AC:
601
AN:
24688
American (AMR)
AF:
0.00387
AC:
66
AN:
17064
Ashkenazi Jewish (ASJ)
AF:
0.00137
AC:
28
AN:
20424
East Asian (EAS)
AF:
0.00199
AC:
55
AN:
27604
South Asian (SAS)
AF:
0.00176
AC:
103
AN:
58576
European-Finnish (FIN)
AF:
0.000754
AC:
32
AN:
42444
Middle Eastern (MID)
AF:
0.00317
AC:
16
AN:
5046
European-Non Finnish (NFE)
AF:
0.000967
AC:
976
AN:
1008976
Other (OTH)
AF:
0.00327
AC:
166
AN:
50708
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.440
Heterozygous variant carriers
0
85
170
254
339
424
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00670
AC:
991
AN:
147922
Hom.:
6
Cov.:
29
AF XY:
0.00670
AC XY:
484
AN XY:
72278
show subpopulations
African (AFR)
AF:
0.0200
AC:
807
AN:
40308
American (AMR)
AF:
0.00326
AC:
49
AN:
15016
Ashkenazi Jewish (ASJ)
AF:
0.00292
AC:
10
AN:
3420
East Asian (EAS)
AF:
0.00206
AC:
10
AN:
4866
South Asian (SAS)
AF:
0.00322
AC:
15
AN:
4656
European-Finnish (FIN)
AF:
0.000710
AC:
7
AN:
9854
Middle Eastern (MID)
AF:
0.00360
AC:
1
AN:
278
European-Non Finnish (NFE)
AF:
0.00120
AC:
80
AN:
66586
Other (OTH)
AF:
0.00581
AC:
12
AN:
2064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
50
100
151
201
251
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000632
Hom.:
2

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
May 13, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 10, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Dec 23, 2014
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Apr 14, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Coffin-Siris syndrome 1 Benign:1
Aug 22, 2019
Centre for Mendelian Genomics, University Medical Centre Ljubljana
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was classified as: Likely benign. The following ACMG criteria were applied in classifying this variant: BS2,BP3,BP6. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
4.7
Mutation Taster
=78/22
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs587779747; hg19: chr6-157099981; COSMIC: COSV51656229; COSMIC: COSV51656229; API